Dem Ilhan Omar’s ‘Peaceful Protestors’ Rhetoric Doesn’t Reflect the Violent Reality on the...
FAFO in Real Time: Leftist Gets Secret Service Visit Over 'What She Deserves'...
Tech Workers Mistaken for ICE Agents and Accosted by Flash Mob
Tiffany Cross Accuses Pete Seat of Lying About CNN's MN Report — Then...
Hot Take: The Killing of Renee Good Was 'Rooted in Misogyny'
Kitchen Crusader: Utensil Armored Wannabe Superhero Seeks Social Justice Gets Ruthlessly M...
Two Women Plead Guilty to Running $68 Million Medicaid Fraud Scheme
While Media Looks Away, Iran Hires Terrorist Militias to Slaughter Protesters in the...
Axios: Private GOP Polls Show Declining Support for Immigration Enforcement
Jacksonville Mayor Says Video of Woman Punching Florida Trooper ‘Came From a Place...
At Least 11 Alleged ICE Vehicles Vandalized at Minneapolis Hotel Overnight
Mayor Pete's Latest Brainwave: Amend the Constitution to Strip Corporations of Free Speech...
Minneapolis Chaos: Conservative Jake Lang Stabbed in Mob Assault – 'The Tolerant Left'...
Eric Swalwell Says That as Governor, He Will Revoke ICE Agents' Driver's Licenses
Democrat Activist Fear Mongers The SAVE Act, Senator Mike Lee Is Having None...

Christina Pushaw busts the AP for acknowledging a COVID treatment fact they shamed Ron DeSantis for pointing out just a few months ago

Yesterday, the Associated Press’ Matthew Perrone reported a possible setback for a couple of COVID19 treatments, including Regeneron.

Advertisement

More from the AP:

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren’t expected to launch for at least several months.

The fact that Regeneron may not be as effective against the omicron variant as it’s been against others is noteworthy enough. But Gov. Ron DeSantis’ press secretary Christina Pushaw finds something else noteworthy, too:

Things sure have changed, haven’t they? Recall this past August, when the AP was entertaining the idea that DeSantis was promoting sketchy Regeneron in some kind of quid pro quo scheme because one of his top donors had invested money in Regeneron, making DeSantis shady AF and not to be trusted.

Advertisement

Pushaw called out the AP then.

Just like she’s calling out the AP now.

We’ve got whiplash.

And Pushaw’s got one last question for the AP:

Join the conversation as a VIP Member

Recommended

Trending on Twitchy Videos

Advertisement
Advertisement
Advertisement